[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer].
Yukio Inuyama(Hokkaido University), T Taguchi(Japan Society of Chemotherapy), A Konno, S Takeoda, Satoru Ebihara(Tohoku University), Akikatu KATAURA, Kayo Togawa, Shingo Baba, Takashi Matsunaga(Shiga University of Medical Science), Akira Kubota, Hideaki Miyake(Kobe University), Yuki Sasaki(Hokkaido University), Akihiko Kida, Shinkichi Kamata, H. Moriyama, N Kono(Tokyo Medical and Dental University), Jin Kanzaki(Keio University), G Ichikawa, Shigeru Saijo(Miyagi Prefectural Hospital Organization), Miki Sakai, H Saito, H Matsuura, M. Tsukuda, Minoru Horiuchi, Bunsuke Satake
PubMed
January 1, 1999
Cited by 21
Related Papers
Treatment of Unexplained Chronic Cough
|CHEST Journal|2015|360
Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score
|Hepatology|2004|359
Anatomy and Neurophysiology of Cough
|CHEST Journal|2014|283
Chronic Cough Due to Gastroesophageal Reflux in Adults
|CHEST Journal|2016|225
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
|Journal of Gastroenterology|2009|205